NEW YORK, NY — As the sun sets on October 13, 2026, the global architectural landscape will undergo a profound transformation. From the spire of One World Trade Center in New York to the mist-covered falls of Niagara and the modern terminals of Mactan-Cebu Airport in the Philippines, more than 325 landmarks will be bathed in a specific triad of colors: teal, green, and pink.
This coordinated display marks the highlight of National Metastatic Breast Cancer (MBC) Awareness Day, anchored by the #LightUpMBC campaign. Organized by METAvivor Research and Support, the initiative aims to pierce the "pink veil" of traditional breast cancer awareness, bringing much-needed attention and funding to the only form of breast cancer that kills: Stage 4.
Main Facts: A Global Beacon for the Forgotten Stage
The 2026 #LightUpMBC campaign represents the largest coordinated effort in the history of metastatic breast cancer advocacy. Spanning all 50 U.S. states and reaching into 20 countries and 195 cities, the scale of the event underscores a growing global demand for research specifically targeting late-stage disease.
Metastatic breast cancer, also referred to as Stage 4, occurs when cancer cells break away from the primary site in the breast and travel through the lymphatic system or bloodstream to settle in distant organs—most frequently the bones, liver, lungs, or brain. Unlike early-stage breast cancer, which is often treated with curative intent, MBC is currently incurable.
The campaign’s signature colors carry deep symbolic weight, designed to differentiate the metastatic community from the broader "pink ribbon" movement:
- Teal: Symbolizes healing and understanding.
- Green: Represents the triumph of spring over winter, signifying renewal, hope, and the persistence of life.
- Pink: Acknowledges the cancer’s origin in the breast.
Beyond the visual spectacle of illuminated bridges and skyscrapers, the campaign features a flagship digital event: #LightUpMBC Live. Streaming at 8 p.m. ET / 5 p.m. PT, the broadcast serves as a virtual town hall, blending scientific education, patient testimonials, and world-class musical performances. Hosted by Tami Eagle Bowling, an 11-year MBC survivor, and Broadway star Kara Lindsay, the program is designed to turn global awareness into tangible research funding.
Chronology: From a Single Bridge to a Global Movement
The origins of #LightUpMBC are rooted in a personal promise and a local tribute. The movement was sparked in 2017 by the late Jessica Moore and her best friend, Laura Inahara. Moore, who was diagnosed with metastatic breast cancer at the age of 32, noticed a stark disconnect between the celebratory "survivorship" tone of October’s Breast Cancer Awareness Month and the reality of those living with a terminal diagnosis.
Moore’s initial wish was modest: to see a single local landmark illuminated in the MBC awareness colors to validate the struggle of Stage 4 patients. Following her passing at age 36, Inahara took up the mantle, turning that wish into a grassroots phenomenon.
- 2017: The Memorial Bridge, connecting Portsmouth, New Hampshire, to Kittery, Maine, became the first landmark to light up for MBC.
- 2018–2021: The campaign gained momentum through social media, with patients and families petitioning local governments to light city halls and smaller bridges.
- 2022–2025: METAvivor officially integrated #LightUpMBC as its primary public-facing awareness vehicle. The number of participating landmarks grew exponentially, crossing the 200-mark as international cities in Europe and Asia joined the cause.
- 2026: The campaign reaches a new zenith, with over 325 landmarks confirmed. This year also marks a significant milestone in fundraising, with the campaign having generated over $2.7 million for MBC research since its inception.
Supporting Data: The Stark Reality of Stage 4
The urgency of the #LightUpMBC campaign is backed by sobering epidemiological data. According to the National Cancer Institute’s SEER program, approximately 42,670 people in the United States are projected to die from breast cancer in 2026 alone. This equates to roughly 117 deaths every single day.
While survival rates for localized breast cancer have improved dramatically over the last three decades, the statistics for metastatic disease remain a challenge. Approximately 6% of new breast cancer diagnoses are "de novo" metastatic, meaning the cancer has already spread by the time it is first detected. For many others, metastasis occurs years or even decades after they were told they were "cancer-free."
A critical point of contention within the advocacy community is the "funding gap." Historically, only an estimated 7% to 10% of all breast cancer research funding has been directed toward metastatic disease, with the vast majority of resources allocated to prevention, early detection, and primary treatment.
METAvivor Research and Support was founded to address this disparity. It remains the only national organization that dedicated 100% of its net proceeds (after event costs) to Stage 4 research. By 2026, the organization has become a vital lifeline for researchers investigating the mechanisms of metastasis, drug resistance, and the development of "chronic" management strategies that allow patients to live longer, higher-quality lives.
Official Responses: Voices from the Frontlines
The leadership of METAvivor and the founders of the campaign emphasize that #LightUpMBC is about more than just lights; it is about visibility for a population that often feels erased by the "pink" marketing of October.
Dr. Kelly Shanahan, a physician and the Board President of METAvivor, has lived with MBC since 2013. Her perspective bridges the gap between clinical reality and patient advocacy. “When I was diagnosed, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan remarked. “My hope, and the hope of so many others, lies in research. METAvivor-funded research is increasingly important because it focuses on the biology of why cancer spreads and how we can stop it. #LightUpMBC is our biggest contributor to this mission, but it is also a way to bring us together as a community so we don’t feel so alone in the dark.”
Laura Inahara, the founder of #LightUpMBC, reflected on the legacy of her friend Jessica Moore. “Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love. It teaches patients with MBC how to advocate for themselves and has now raised over $2.7 million for critical research. We are showing the world that Stage 4 needs more than a ribbon; it needs a cure.”
The 2026 live broadcast also features a high-profile roster of supporters from the arts, highlighting the cultural impact of the movement. Performers including two-time Tony Award winner Victoria Clark and Tony nominee Dorian Harewood are set to perform, lending their voices to a cause that affects 1 in 8 women and a significant number of men globally.
Implications: Shifting the Paradigm from Terminal to Survivable
The long-term implications of the #LightUpMBC campaign extend into the realms of oncology, public policy, and social perception. By focusing exclusively on Stage 4, METAvivor is driving a paradigm shift in how the medical community approaches metastatic disease.
1. Transforming Treatment Goals
The ultimate goal of the research funded by this campaign is to transition metastatic breast cancer from a terminal diagnosis to a manageable chronic condition, similar to HIV or Type 1 diabetes. This requires a shift in research focus toward "liquid biopsies," personalized genomic profiling, and immunotherapy combinations that can overcome treatment resistance.
2. Bridging the Awareness Gap
The "Pink Ribbon" movement has been incredibly successful at promoting mammography and early detection. However, it has inadvertently created a stigma around those who "fail" treatment or whose cancer returns. #LightUpMBC forces a public conversation about the reality that early detection is not a guarantee of survival. This honesty is essential for securing the legislative and financial support needed for late-stage patients.
3. Global Advocacy Networks
The participation of landmarks in countries like Scotland, the Philippines, and Canada signals the globalization of MBC advocacy. As international registries and research collaborations grow, the data gathered from METAvivor-funded grants could have implications for oncology protocols worldwide, particularly in regions where access to advanced Stage 4 therapies is limited.
4. The Power of Patient-Led Science
METAvivor’s unique model—where both scientific peers and patient advocates review grant applications—ensures that funded research is not just scientifically sound but also "patient-centric." This ensures that quality of life and the extension of life are weighted equally in the quest for a cure.
As the lights fade on the morning of October 14, the impact of #LightUpMBC will continue through the laboratories and clinics funded by the night’s proceeds. For the 168,000 Americans currently living with metastatic breast cancer, the global display of teal, green, and pink is a reminder that while the disease is currently incurable, they are no longer invisible.
How to Participate:
The public is encouraged to visit www.lightupmbc.org to find a map of participating landmarks. Supporters are asked to share photos on social media using the hashtags #LightUpMBC and #METAvivor to help amplify the message. Donations made during the #LightUpMBC Live stream go directly toward funding Stage 4 research grants.
About the Author
